Search

everythinglearnresearchcommunity

for

Search:↓

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Diagnosing PCOS in teenagers is hard because its symptoms often look like normal puberty, and there's a need for better diagnosis methods and agreement on criteria.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

The conclusion is that the best approach for treating Female Pattern Hair Loss is a combination of different treatments.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

SHBG binding properties are unchanged in male liver cirrhosis patients.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.